Eonji Na

Korea Institute of Drug Safety and Risk Management, Republic of Korea

Poster(s):

• (A-261) Anaphylaxis Risk Across Cephalosporin Generations and Cefaclor: Insights from a Nationwide Case-Crossover Study (2011–2023)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLB-030) Risk of Acute Kidney Injury with Non-vitamin K Antagonist Oral Anticoagulants Use: A Retrospective Cohort Study
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET